Search
for

    Sort by

    Research 451–480 of 1000+

    1. Regenerative medicine strategies for hair growth and regeneration: A narrative review of literature Regenerative Therapy · 2022 · 8 citations
    2. Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia Translational Andrology and Urology · 2020 · 7 citations
    3. Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview SpringerPlus · 2016 · 7 citations
    4. Clinicopathological characteristics and treatment outcomes of fibrosing alopecia in a pattern distribution: A retrospective cohort study Journal of the European Academy of Dermatology and Venereology · 2021 · 7 citations
    5. LINCS Dataset-Based Repositioning of Dutasteride as an Anti-Neuroinflammation Agent Brain Sciences · 2021 · 6 citations
    6. Aphalangia possibly linked to unintended use of finasteride during early pregnancy Annals of Saudi Medicine · 2009 · 6 citations
    7. An observational study of the association between androgenetic alopecia and size of the prostate International Journal of Trichology · 2016 · 6 citations
    8. Plants as potential active components in treatment of androgenetic alopecia Herba Polonica · 2014 · 6 citations
    9. The pregnant urologist BJU international · 2017 · 5 citations
    10. Saw palmetto and finasteride in the treatment of category-iii prostatitis/chronic pelvic pain syndrome Current Urology Reports · 2005 · 5 citations
    11. Non-surgical management of BPH: An updated review of current literature and state of the art on natural compounds and medical therapy Archivio Italiano di Urologia e Andrologia · 2024 · 5 citations
    12. Brazilian blood donation eligibility criteria for dermatologic patients Anais Brasileiros de Dermatologia · 2012 · 5 citations
    13. Reply to Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice 2021 · 4 citations
    14. Patterns of Care for Newly Diagnosed Benign Prostatic Hyperplasia in the United States 2016 · 4 citations
    15. Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments Clinical Epidemiology · 2022 · 4 citations
    16. Drug-induced gynecomastia: A systematic review and meta-analysis of randomized clinical trials Archivio italiano di urologia andrologia · 2021 · 4 citations
    17. Androgenetic alopecia in women and men: Italian guidelines adapted from European Dermatology Forum/European Academy of Dermatology and Venereology guidelines Giornale italiano di dermatologia e venereologia · 2020 · 4 citations
    18. Impact of anti-androgen therapies on COVID-19 susceptibility: a case-control study in male population from two COVID-19 regional centers of Lombardy (Italy) medRxiv (Cold Spring Harbor Laboratory) · 2020 · 4 citations
    19. Frontal fibrosing alopecia: efficacy of treatment modalities DOAJ (DOAJ: Directory of Open Access Journals) · 2019 · 4 citations
    20. Off-label prescriptions: patient safety first The Lancet Oncology · 2011 · 4 citations
    21. Hairless or fertile? Finasteride leads to epididymal changes and infertility in rats Fertility and Sterility · 2012 · 3 citations
    22. Effects of finasteride on the morphology of polycystic ovaries International journal of gynaecology and obstetrics · 2004 · 3 citations
    23. Serenoa Repens (Saw Palmetto) for Lower Urinary Tract Symptoms (LUTS): The Evidence for Efficacy and Safety of Lipidosterolic Extracts. Part III Uro · 2021 · 3 citations
    24. Optimal Management of Frontal Fibrosing Alopecia: A Practical Guide Clinical, Cosmetic and Investigational Dermatology · 2020 · 3 citations
    25. Steroid Hormones Elsevier eBooks · 2016 · 3 citations
    26. Extraordinary claims without extraordinary evidence: controversy on anti‐androgen therapy for COVID‐19 Journal of the European Academy of Dermatology and Venereology · 2021 · 3 citations
    27. Hair, Hormones, and High-Risk Prostate Cancer Journal of Clinical Oncology · 2014 · 3 citations
    28. Is 3α, 17β-androstanediol-glucuronide a diagnostic marker in women with androgenic manifestations? Gynecological Endocrinology · 1992 · 3 citations
    29. MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED? The Journal of Urology · 2016 · 2 citations
    30. Testosterone metabolite nonessential for androgen effects Nature Reviews Endocrinology · 2012 · 2 citations